ClinicalTrials.Veeva

Menu

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

Stanford University logo

Stanford University

Status

Terminated

Conditions

Breast Cancer

Treatments

Device: NACgraft

Study type

Interventional

Funder types

Other

Identifiers

NCT04534010
IRB-55153
BRS0117 (Other Identifier)

Details and patient eligibility

About

The goal of this study is to evaluate safety and healing time after nipple-areolar complex (NAC) reconstruction with the BioAesthetics' decellularized human nipple-areolar complex (dcl-hNAC) graft in patients who have had autologous breast reconstruction for breast cancer. Secondary objectives will be to assess patient satisfaction, patient well-being, patient self-esteem, patient body image, patient psychological well-being, nipple dimensions and sensitivity following NAC reconstruction surgery with the BioAesthetics' dcl-hNAC graft.

Enrollment

6 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient age 18-65
  • Patient desires NAC grafting ≥3 months after autologous breast reconstruction
  • Patient agrees to sleep on back until grafts healed (6 weeks)
  • Patient agrees to abstain from aspirin, alcohol, or excessive caffeine until grafts healed (6 weeks)
  • Patient agrees to not undergo NAC tattooing until completing study (12 months)
  • Patient is able to understand and willing to sign informed consent.

Exclusion criteria

  • History of delayed wound healing
  • history of Vitamin C deficiency
  • history of diabetes (Type I or Type II)
  • current BMI<18.5 or >40 kg/m,
  • patient has any other uncontrolled comorbidity.
  • Patient has a history of allergic reaction to any decellularized biologic matrix product.
  • Patient is currently smoking or using tobacco or nicotine products (i.e. patch, gum, or nasal spray) or has used such products in the past 12 months.
  • Patient is currently receiving radiation or chemotherapy or received radiation to the breast wall.
  • Patient has a history of prior NAC reconstruction
  • Patient has had NAC tattooing.
  • Patient is pregnant, breastfeeding or planning to become pregnant during the study period.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

NACgraft patients
Experimental group
Description:
uni- or bilateral engraftment surgery will be performed
Treatment:
Device: NACgraft

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Shannon Meyer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems